CPT1A and hepatocellular carcinoma: CPT1 has been extensively studied in a variety of cancers, and overexpression of CPT1A accelerates tumor development by stimulating FAO in prostatic cancer (112), breast cancer (113), gastric cancer (114), and hepatocellular cancer (115).